| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Qualymed Grup S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 65.615 | 64.945 | 63.846 | 62.675 | 61.461 | 60.296 | 58.959 | 59.142 | 58.962 | - |
| Current Assets | 137 | 136 | 133 | 131 | 128 | 126 | 123 | 123 | 123 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 56 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | - |
| Cash | 81 | 80 | 79 | 77 | 76 | 74 | 73 | 73 | 73 | - |
| Shareholders Funds | -11.811 | -11.691 | -11.493 | -11.282 | -11.064 | -10.854 | -10.613 | -10.646 | -10.614 | - |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | - |
| Debts | 77.563 | 76.772 | 75.473 | 74.088 | 72.653 | 71.276 | 69.695 | 69.911 | 69.699 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7414 - 7414" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Qualymed Grup S.r.l.